News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Galea Life Sciences Completes Financing


3/6/2008 10:39:22 AM

MIAMI, March 6, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN), whose BioSource Therapeutics, Inc. (BST) subsidiary manufactures and markets Nutraplete(tm) Therapeutic Drink Mix, the first dietary supplement produced specifically for people living with HIV/AIDS, has completed a $275,000 convertible debenture financing with Trafalgar Capital Specialized Investment Fund, Luxembourg.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES